Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Microcirculation in Sepsis
NCT02109965Phase 4Terminated
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in sepsis, septic shock, sponsored by National Taiwan University Hospital. Started Jul 2014; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT02109965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02109965.